Just another crappy commentary: the future of fecal microbiota transplantation

References

• Juul FE, Garborg K, Bretthauer M, et al. Fecal microbiota transplantation for primary clostridium difficile infection. N Engl J Med. 2018;378(26):2535–2536. Epub 2018/06/05. PubMed PMID: 29860912.
   PubMed Web of Science ®Google Scholar
• Ianiro G, Maida M, Burisch J, et al. Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: a systematic review and meta-analysis. United European Gastroenterol J. 2018;6(8):1232–1244. Epub 2018/ 10/06. PubMed PMID: 30288286; PMCID: PMC6169051.
   PubMed Web of Science ®Google Scholar
• Lederberg J. ‘Ome Sweet’ Omics: A geneological treasury of words. The Scientist. 2001.
   Google Scholar
• Bauer H, Horowitz RE, Levenson SM, et al. The response of the lymphatic tissue to the microbial flora. Studies on germfree mice. Am J Pathol. 1963;42:471–483. Epub 1963/04/01. PubMed PMID: 13966929; PMCID: PMC1949649.
   PubMed Web of Science ®Google Scholar
• Clayton TA, Baker D, Lindon JC, et al. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci U S A. 2009;106(34):14728–14733. Epub 2009/08/12. PubMed PMID: 19667173; PMCID: PMC2731842.
   PubMed Web of Science ®Google Scholar
• Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, et al. Separating host and microbiome contributions to drug pharmacokinetics and toxicity. Science. 2019;363(6427). Epub 2019/02/09. PubMed PMID: 30733391; PMCID: PMC6533120. DOI:10.1126/science.aat9931
   Web of Science ®Google Scholar
• Wang Y, Wiesnoski DH, Helmink BA, et al. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nat Med. 2018; 12(24):1804–1808. PubMed PMID: 30420754; PMCID: PMC6322556. Epub 2018/11/14.
   Google Scholar
• Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91–97. Epub 2017/ 11/04. PubMed PMID: 29097494.
   PubMed Web of Science ®Google Scholar
• Dinh A, Fessi H, Duran C, et al. Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study. J Hosp Infect. 2018;99(4):481–486. Epub 2018/ 02/27. PubMed PMID: 29477634.
   PubMed Web of Science ®Google Scholar
• Costello SP, Soo W, Bryant RV, et al. Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Aliment Pharmacol Ther. 2017;46(3):213–224. Epub 2017/ 06/15. PubMed PMID: 28612983.
   PubMed Web of Science ®Google Scholar
• Ding X, Li Q, Li P, et al. Long-term safety and efficacy of fecal microbiota transplant in active ulcerative colitis. Drug Saf 2019. Epub 2019/04/12. PubMed PMID: 30972640. DOI: 10.1007/s40264-019-00809-2.
   PubMed Web of Science ®Google Scholar
• Li P, Zhang T, Xiao Y, et al. Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn’s disease. Appl Microbiol Biotechnol. 2019;103(1):349–360. Epub 2018/ 10/26. PubMed PMID: 30357440; PMCID: PMC6311185. DOI: 10.1007/s00253-018-9447-x.
   PubMed Web of Science ®Google Scholar
• Huang HL, Chen HT, Luo QL, et al. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota. J Dig Dis. 2019. Epub 2019/05/10. PubMed PMID: 31070838. DOI:10.1111/1751-2980.12756.
   Web of Science ®Google Scholar
• Ianiro G, Eusebi LH, Black CJ, et al. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2019;50(3):240–248. Epub 2019/ 05/29. PubMed PMID: 31136009.
   PubMed Web of Science ®Google Scholar
• Allegretti JR, Kassam Z, Carrellas M, et al. Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial. Am J Gastroenterol. 2019. Epub 2019/ 02/08. PubMed PMID: 30730351. DOI:10.14309/ajg.0000000000000115.
   Web of Science ®Google Scholar
• Ohara T. Identification of the microbial diversity after fecal microbiota transplantation therapy for chronic intractable constipation using 16s rRNA amplicon sequencing. PLoS One. 2019;14(3):e0214085. Epub 2019/03/20. PubMed PMID: 30889205; PMCID: PMC6424423.
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Kakiyama G, Savidge T, et al. Antibiotic-associated disruption of microbiota composition and function in cirrhosis is restored by fecal transplant. Hepatology. 2018;68(4):1549–1558. Epub 2018/04/18. PubMed PMID: 29665102.
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Salzman NH, Acharya C, et al. Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial. Hepatology. 2019 PubMed PMID: 31038755. Epub 2019/ 05/01. DOI:10.1002/hep.30690.
   Google Scholar
• Mehta R, Kabrawala M, Nandwani S, et al. Preliminary experience with single fecal microbiota transplant for treatment of recurrent overt hepatic encephalopathy-A case series. Indian J Gastroenterol. 2018;37(6):559–562. Epub 2018/11/27. PubMed PMID: 30474827.
   PubMed Web of Science ®Google Scholar
• Kragsnaes MS, Kjeldsen J, Horn HC, et al. Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial. BMJ Open. 2018;8(4):e019231. Epub 2018/04/29. PubMed PMID: 29703851; PMCID: PMC5922473.
   PubMed Web of Science ®Google Scholar
• Kakihana K, Fujioka Y, Suda W, et al. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. Blood. 2016;128(16):2083–2088. Epub 2016/07/28. PubMed PMID: 27461930; PMCID: PMC5085256.
   PubMed Web of Science ®Google Scholar
• Cai TT, Ye XL, Yong HJ, et al. Fecal microbiota transplantation relieve painful diabetic neuropathy: A case report. Medicine (Baltimore). 2018;97(50):e13543. Epub 2018/ 12/19. PubMed PMID: 30558014; PMCID: PMC6320208.
   PubMed Web of Science ®Google Scholar
• Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastro. 2012;143(4):913–6 e7. Epub 2012/06/26. PubMed PMID: 22728514.
   PubMed Web of Science ®Google Scholar
• Kootte RS, Levin E, Salojarvi J, et al. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metab. 2017;26(4):611–9 e6. Epub 2017/10/06. PubMed PMID: 28978426.
   PubMed Web of Science ®Google Scholar
• Smits LP, Kootte RS, Levin E, et al. Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-n-oxide production and vascular inflammation in patients with metabolic syndrome. J Am Heart Assoc. 2018;7(7). Epub 2018/03/28. PubMed PMID: 29581220; PMCID: PMC5907601. DOI:10.1161/JAHA.117.008342
   PubMed Web of Science ®Google Scholar
• Khoruts A, Brandt LJ. Fecal microbiota transplant: a rose by any other name. Am J Gastroenterol. 2019;114(7):1176. Epub 2019/ 06/18. PubMed PMID: 31205129.
   PubMed Web of Science ®Google Scholar
• Dailey FE, Turse EP, Daglilar E, et al. The dirty aspects of fecal microbiota transplantation: a review of its adverse effects and complications. Curr Opin Pharmacol. 2019;49:29–33. Epub 2019/05/20. PubMed PMID: 31103793.
   PubMed Web of Science ®Google Scholar
• Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109(7):1065–1071. Epub 2014/06/04. PubMed PMID: 24890442; PMCID: PMC5537742.
   PubMed Web of Science ®Google Scholar
• Rosenbaum JT, Asquith M, et al. The microbiome and HLA-B27-associated acute anterior uveitis. Nat Rev Rheumatol. 2018;14:704–713. Epub 2018/10/12. PubMed PMID: 30301938.
   PubMed Web of Science ®Google Scholar
• Bibbo S, Ianiro G, Giorgio V, et al.. The role of diet on gut microbiota composition. Eur Rev Med Pharmacol Sci. 2016;20(22): 4742–4749. Epub 2016/12/03. . PubMed PMID: 27906427
   PubMed Web of Science ®Google Scholar
• Manfredo Vieira S, Hiltensperger M, Kumar V, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science. 2018;359(6380):1156–1161. Epub 2018/03/29. PubMed PMID: 29590047. DOI: 10.1126/science.aar7201
   PubMed Web of Science ®Google Scholar
• Roberts AB, Gu X, Buffa JA, et al. Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential. Nat Med. 2018;24(9):1407–1417. Epub 2018/08/08. PubMed PMID: 30082863; PMCID: PMC6129214.
   PubMed Web of Science ®Google Scholar
• Zhuang R, Ge X, Han L, et al. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis. Obes Rev. 2019;20(6):883–894. Epub 2019/ 03/15. PubMed PMID: 30868721.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature. 2007;449(7164):804–810. Epub 2007/ 10/19. PubMed PMID: 17943116; PMCID: 3709439.
   PubMed Web of Science ®Google Scholar
• Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65. PubMed PMID: 20203603; PMCID: 3779803. .
   PubMed Web of Science ®Google Scholar